First Manhattan’s Neurotrope, Inc. Common NTRP Stock Holding History

First Manhattan’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-500	Closed	–	–	1452
2020 Q3	$0	Hold	500	–	–	﹤0.01%	1510
2020 Q2	$0	Hold	500	–	–	﹤0.01%	1515
2020 Q1	$0	Hold	500	–	–	﹤0.01%	1499
2019 Q4	$0	Hold	500	–	–	﹤0.01%	1400
2019 Q3	$0	Hold	500	–	–	﹤0.01%	1436
2019 Q2	$4K	Hold	500	–	–	﹤0.01%	1273
2019 Q1	$2K	Hold	500	–	–	﹤0.01%	1340
2018 Q4	$1K	Hold	500	–	–	﹤0.01%	1347
2018 Q3	$4K	Hold	500	–	–	﹤0.01%	1312
2018 Q2	$4K	Hold	500	–	–	﹤0.01%	1276
2018 Q1	$4K	Hold	500	–	–	﹤0.01%	1290
2017 Q4	$3K	Hold	500	–	–	﹤0.01%	1371
2017 Q3	$2K	Hold	500	–	–	﹤0.01%	1380
2017 Q2	$4K	Buy	+500	New	+$5.34K	﹤0.01%	1283

Other funds holding NTRP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

First Manhattan's NTRP Position: Q4 2020 in Review

First Manhattan sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 500 shares.

First Manhattan first reported a position in NTRP in Q2 2017 and held it in 14 quarters. The position peaked at $4K in Q2 2019. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

First Manhattan reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
First Manhattan sold 500 Neurotrope, Inc. Common shares in Q4 2020.
First Manhattan first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 14 quarters.
First Manhattan's Neurotrope, Inc. Common position peaked at $4K in Q2 2019.
1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on First Manhattan's 13F filing for Q4 2020, filed 16 Feb 2021.